Apyx Medical: Pay

Apyx Medical paid its 4 named executives $3.2M in total in FY2025 (Dec). CEO Charles D. Goodwin was paid $1.2M of that.

Pay$100 in the stock at the end of FY21 → $27
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Charles D. GoodwinCEO and Director
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years
Mathew HillCFO, Treasurer and Secretary
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years
Shawn RomanChief Operating Officer
FY2025 (Dec)
FY2023 (Dec)
2 years
Moshe CitronowiczSenior Vice President
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 2 peers with pay on file was $1.1M. The CEO of Apyx Medical was paid $1.2M, 8% above the median.

  1. 1Electromed
  2. 2Apyx Medical
  3. 3Cytosorbents
  4. 4BIOLASE, Inc.Not disclosed
  5. 5CVRxNot disclosed
  6. 6NeuroPaceNot disclosed
  7. 7NeuroneticsNot disclosed
  8. 8PulmonxNot disclosed
  9. 9Sensus HealthcareNot disclosed
  10. 10TELA BioNot disclosed
  11. 11Utah Medical ProductsNot disclosed
  12. 12Xtant Medical Holdings, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.